FTC stops marketers of anti-aging supplement ReJuvenation from making false “cure-all” claims

FTC sues Beam Financial

The Federal Trade Commission (FTC) stopped the marketer of ReJuvenation from making false claims that the product can cure all age-related illnesses such as Alzheimer’s disease, Parkinson’s disease, and Crohn’s disease.

The FTC filed a complaint against Quantum Wellness Botanical Institute, LLC (Quantum Wellness), the marketer and distributor of ReJuvenation.The company’s CEO Fred Auzenne and his business associates Maria Gutierrez Veloso and Danica Collins were also named as defendants in the lawsuit.

Auzenne owns 50 percent of Quantum Wellness while Veloso and Collins own 19 percent. These individuals are responsible for the company’s baseless health claims in advertising and selling the anti-aging supplement.

In the lawsuit, the FTC stated that the defendants advertised and sold ReJuvenation as a virtual cure-all for age-related ailments to consumers nationwide. They promoted the product to consumers through direct mail, postcards, e-mails, and multiple websites from March 2014 to February 2016.